PMC:7029759 / 6837-7121 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"175","span":{"begin":6,"end":14},"obj":"Disease"},{"id":"192","span":{"begin":186,"end":187},"obj":"Gene"},{"id":"193","span":{"begin":214,"end":223},"obj":"Species"}],"attributes":[{"id":"A175","pred":"tao:has_database_id","subj":"175","obj":"MESH:D007239"},{"id":"A192","pred":"tao:has_database_id","subj":"192","obj":"Gene:43740568"},{"id":"A193","pred":"tao:has_database_id","subj":"193","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"tween infected cells and other receptor-bearing cells around them, emphasizing that the S protein does not function in just the virion state alone.\nA neutralizing antibody targeting the S protein on the surface of 2019-nCoV is likely the first therapy contemplated by biomedical resea"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T136","span":{"begin":88,"end":97},"obj":"PG_1"},{"id":"T135","span":{"begin":163,"end":171},"obj":"GO:0042571"},{"id":"T134","span":{"begin":186,"end":195},"obj":"PG_1"},{"id":"T133","span":{"begin":214,"end":223},"obj":"SP_7"}],"text":"tween infected cells and other receptor-bearing cells around them, emphasizing that the S protein does not function in just the virion state alone.\nA neutralizing antibody targeting the S protein on the surface of 2019-nCoV is likely the first therapy contemplated by biomedical resea"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T20","span":{"begin":15,"end":20},"obj":"Body_part"},{"id":"T21","span":{"begin":48,"end":53},"obj":"Body_part"},{"id":"T22","span":{"begin":90,"end":97},"obj":"Body_part"},{"id":"T23","span":{"begin":163,"end":171},"obj":"Body_part"},{"id":"T24","span":{"begin":188,"end":195},"obj":"Body_part"}],"attributes":[{"id":"A20","pred":"fma_id","subj":"T20","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A21","pred":"fma_id","subj":"T21","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A22","pred":"fma_id","subj":"T22","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A23","pred":"fma_id","subj":"T23","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A24","pred":"fma_id","subj":"T24","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"tween infected cells and other receptor-bearing cells around them, emphasizing that the S protein does not function in just the virion state alone.\nA neutralizing antibody targeting the S protein on the surface of 2019-nCoV is likely the first therapy contemplated by biomedical resea"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T58","span":{"begin":15,"end":20},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T59","span":{"begin":48,"end":53},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T60","span":{"begin":148,"end":149},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"tween infected cells and other receptor-bearing cells around them, emphasizing that the S protein does not function in just the virion state alone.\nA neutralizing antibody targeting the S protein on the surface of 2019-nCoV is likely the first therapy contemplated by biomedical resea"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T14","span":{"begin":90,"end":97},"obj":"Chemical"},{"id":"T15","span":{"begin":188,"end":195},"obj":"Chemical"}],"attributes":[{"id":"A14","pred":"chebi_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"tween infected cells and other receptor-bearing cells around them, emphasizing that the S protein does not function in just the virion state alone.\nA neutralizing antibody targeting the S protein on the surface of 2019-nCoV is likely the first therapy contemplated by biomedical resea"}